Markers near the nested genes G72 and G30 on chromosome 13q33 have been implicated in the etiology of schizophrenia and, recently, bipolar affective disorder (BPAD). Hattori et al (2003) reported that single-nucleotide polymorphisms (SNPs) near the G72/G30 locus were associated with BPAD in a sample of 22 pedigrees, and that SNP haplotypes were associated in a second, larger sample of triads. The present study attempts to replicate this finding in an independent case-control sample. Six SNPs near the G72/G30 locus, including the most strongly associated markers in the previous study, were tested in 139 cases and 113 ethnically matched controls. Significant association was detected between BPAD and two adjacent SNPs (smallest P ¼ 0.007; global P ¼ 0.024). Haplotype analysis produced additional support for association (smallest P ¼ 0.004; global P ¼ 0.004). Analysis of 31 unlinked microsatellite markers detected no population stratification in the cases or controls studied. Although the associated alleles and haplotypes differ from those previously reported, these new results provide further evidence, in an independent sample, for an association between BPAD and genetic variation in the vicinity of the genes G72 and G30.
Bipolar affective disorder (BPAD) is a common and often severe mental illness marked by recurrent episodes of mania and clinical depression. That BPAD runs in families has long been accepted. Adoption studies show that this familiality has a genetic basis, and twin studies demonstrate a high degree of heritability. 1 While a single gene might play a major role in some rare families, multiple genes and environmental factors are usually considered to underlie BPAD susceptibility in most families. Several chromosomal regions have been implicated by genetic linkage and association studies as potential sites of susceptibility loci, 2 but findings have proven difficult to replicate consistently. 3 Hence, BPAD is a complex genetic disorder most likely involving multiple genes, but none has been unambiguously identified so far.
Chumakov et al 4 reported that genetic variation near two novel genes on chromosome 13q33, G72 and G30 was associated with schizophrenia. Nearby chromosomal regions have been implicated in BPAD by genetic linkage studies. 5, 6 On the basis of these findings, Hattori et al 7 investigated single-nucleotide polymorphisms (SNPs) near the G72/G30 locus in families with BPAD. Significant association with individual SNPs and haplotypes was detected in a sample of 22 pedigrees, and supported by haplotype analysis in a second sample of triads. These findings are important, but the significance levels were modest, 8, 9 and the sample showing the initial association was small. These limitations, along with the well-recognized risk of false-positive findings in genetic association studies, indicate the need for additional studies in independent samples.
The present study was based on an independent case-control sample. Six SNPs near the G72/G30 locus, including the most strongly associated markers in the previous study, 7 were tested in BPAD cases and ethnically matched controls. Two markers were found to be significantly associated with BPAD, and haplotype analysis produced additional support for association with several distinct haplotypes. Analysis of a set of unlinked microsatellite markers detected no significant population stratification in the cases or controls studied. Although the associated alleles and haplotypes differ from those reported previously, these new results provide further evidence, in an independent sample, for an association between BPAD and genetic variation in the vicinity of the G72/G30 locus.
Materials and methods

Study samples
Family ascertainment and evaluation methods are detailed elsewhere. 10 Briefly, the case sample consisted of 139 unrelated probands with a diagnosis of bipolar I, bipolar II, or schizo-affective bipolar disorder collected as part of a genetic linkage study on the basis of a strong family history of major affective disorder. Probands were ascertained primarily in Maryland and Iowa, all reported US birth, and all were self-identified as 'white'. While all probands had a family history of major affective disorder, additional relatives have been collected for only 68 probands, as previously described. 11 The study was approved by the applicable Institutional Review Boards, and informed consent was obtained from all participants.
Subjects were interviewed by a psychiatrist, using the Schedule for Affective Disorders and Schizophrenia-Lifetime Version. 12 Two additional psychiatrists reviewed the interview, family informant data and any medical records, before assigning a best-estimate diagnosis under Research Diagnostic Criteria. 12 The diagnosis of bipolar II disorder (BPII) required recurrent major depression as well as hypomanias. Using these methods, we have achieved excellent diagnostic reliability, with kappa values 40.90.
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A control group of 113 unrelated individuals was assembled from among the founders of the Centre d'Etude du Polymorphisme Humain (CEPH; http:// www.cephb.fr) Utah and French pedigrees (Coriell Institute, NIGMS Human Genetic Cell Repository, Camden, NJ, USA). We excluded the Amish pedigree 880 because of the known history of BPAD in that pedigree.
14 There is no known schizophrenia or BPAD in the CEPH pedigrees we selected (M Lathrop, personal communication, 2/2000), but family members have not undergone psychiatric evaluations. 15 Power estimates were performed with the Genetic Power Calculator (statgen.iop.kcl.ac.uk) under the following parameters: disease prevalence, 0.01; D 0 between disease and marker alleles, 0.8; two-fold increased risk of disease in heterozygotes under an additive model; alpha, 0.05. We estimate that a sample of this size has 85% power to detect association when disease and marker allele frequency (A) ¼ 0.25, 81% power for A ¼ 0.2 and 74% power for A ¼ 0.15.
Markers
We selected for the study seven SNPs reported in Hattori et al, 7 and an additional SNP, rs2027446, which is near the most strongly associated marker in the previous study (rs1935058). Rigorous quality control criteria were applied. All genotype experiments were repeated at least twice, with the requirement of p1 discrepant genotypes per plate. All results were tested for Hardy-Weinberg Equilibrium (HWE) using HWSIM (krunch.med.yale.edu/hwsim), with the requirement of unambiguous HWE within each group. All FP-TDI genotypes (see below) were called with X99% confidence by an automated algorithm. 16 Two SNPs (rs1341402 and rs778294) failed one or more quality control criteria, and were excluded from further analysis.
FP-TDI
SNPs were genotyped by template-directed dyeterminator incorporation with fluorescence polarization detection (FP-TDI) and automated genotype scoring, as detailed elsewhere. 16 Fragments containing the selected SNPs were amplified by polymerase chain reaction (PCR) with primers designed by Oligo 6.0 (Molecular Biology Insights, Inc., Cascade, CO, USA).
PCR-RFLP
Since rs1935058 did not perform well by TDI-FP, we used the PCR-RFLP protocol detailed in Hattori et al, 7 except that primers were redesigned to produce a 250 bp PCR product. PCR products were digested with MnlI restriction endonuclease (NEB, Inc., Beverly, MA, USA). The resulting fragments were separated by electrophoresis on agarose gel (3% Nusieve plus 1% SeaKem agarose; FMC BioProducts, Rockland, ME, USA), stained with ethidium bromide, visualized by UV transillumination, and scored by two independent readers blind to phenotype.
Intermarker linkage disequilibrium (LD)
Intermarker LD was determined for six SNPs spanning 42.5 kb, based on 186 control chromosomes. SNP positions were determined by aligning flanking sequences on the November 2002 build of the Golden Path (http://genome.cse.ucsc.edu). LD was estimated using the ldmax option in GOLD, 17 which uses pairwise haplotype frequencies estimated by an expectation-maximization (EM) algorithm. 18 For this biallelic marker data, GOLD calculates the LD measure delta 219 , as well as the standardized disequilibrium coefficient D 020 .
Marker-trait association testing
Association analysis was performed with Cocaphase 2.35 21 (www.hgmp.mrc.ac.uk). This package performs likelihood ratio tests under a log-linear model of the probability that an allele or haplotype belongs to the case rather than control group, using a standard unconditional logistic regression. The EM algorithm was used to resolve uncertain haplotypes, infer missing genotypes, and provide maximum-likelihood estimates of frequencies. Since the EM algorithm does not accurately estimate haplotype frequencies below 1% 22 , haplotypes o1% in both groups were excluded.
The global null hypothesis that all odds ratios are equal was tested by permutation. The method randomly reassigns the 'case' and 'control' labels in the actual data. The permutation procedure gives a significance level corrected for all markers or haplotypes tested. In all, 10 000 permutations were performed each for the single marker and haplotype tests. When the global test was significant, individual haplotypes were tested for association by grouping all others together and applying the w 2 test with 1 df.
Linkage data Dense chromosome 13 microsatellite data exist for 68 of the cases and their relatives, as previously described. 6 In order to gauge the potential impact of unlinked families on the chromosome 13q33 association results, family-specific NPL scores were calculated in these pedigrees using Genehunter Plus, 23 and an 'enriched' sample was produced by excluding from the analysis those 23 cases belonging to families with NPL scores o0 across the interval from D13S779 to D13S173. These markers lie within 4.6 and 1.7 MB, respectively, of the G72/G30 region on the November 2002 build of the Golden Path (genome.ucsc.edu). We did not exclude the 71 cases without available linkage data, since that would have greatly reduced the sample size and some of these cases may indeed be linked to 13q33.
Testing for population stratification We tested for potential population stratification between cases and controls by using a set of unlinked microsatellite markers genotyped in both probands and controls. Genotypes for probands were obtained as described elsewhere. 11 Genotypes for controls were downloaded from the CEPH website by querying markers with genotypes present in at least 10 CEPH families. Alleles were initially aligned by size, without regard to allele frequencies. This alignment was then crosschecked against a subset of the control sample representing a spread of alleles for each marker. This generated a list of 32 candidate markers whose alleles could be unambiguously aligned. We removed one marker whose genotype distribution was strongly inconsistent with Hardy-Weinberg expectations within the control sample, based on a multiallelic test of HWE, 24 as implemented in MEGA2 (version 2.3; http://watson.hgen.pitt.edu). Allele frequencies of the remaining 31 markers were compared between cases and controls by a w 2 test implemented in STRAT (vers 1.1). 25 This procedure has excellent power to detect stratification with as few as 10 microsatellite markers. 25 This analysis revealed no evidence of population stratification between cases and controls in our sample (w 2 ¼ 147.37, df ¼ 128, P ¼ 0.12).
Results
Intermarker LD
Most of the genotyped SNPs were in tight, and highly significant, LD with each other (Figure 1 ). Three pairs of SNPs, all involving rs954581, were not significantly associated by the w 2 test. Since rs954581 is the most distal marker, these results suggest that the previously described LD block in the G72/G30 region 7 ends distally somewhere between rs947267 and rs954581, which lie 12.6 kb apart on the April 2003 build of the draft human genome sequence (genome.ucsc.edu). The proximal (centromeric) border of the LD block cannot be determined from our data.
Single-marker association analysis
The results of the single-marker case-control association analysis are shown in Table 1 . Significant evidence of association with BPAD was detected (global P-value by permutation test ¼ 0.0238). The adjacent SNPs rs1935062 and rs947267 showed the strongest evidence of association (P ¼ 0.0072 and 0.0403, respectively). In Hattori et al, 7 rs1935062 was also found to be significantly associated with BPAD, while rs947267, although not associated by TDT at Po0.05 in that study, gave a significant result by the linkage partition test.
Haplotype association analysis
Although this study did not generate data for all of the same SNPs as the previous study, 7 by using the five SNPs that were common to both studies, we were able to infer most of the common haplotypes, and all of the associated haplotypes, previously reported (Table 2) . We detected significant association between BPAD and the set of five-marker haplotypes in our sample (global P-value by permutation test ¼ 0.004). Individual haplotype tests showed that the frequencies of several distinct haplotypes differed significantly between cases and controls.
Enrichment for linked cases
All of the above analyses were repeated in the 'enriched' case sample that excluded probands belonging to families not linked to 13q33. Odds ratios were similar or somewhat larger in the enriched sample, and all P-values remained significant despite a 17% reduction in sample size (Tables 1 and 2, right) .
Discussion
This study found evidence of association between BPAD and SNPs near the G72/G30 locus on chromosome 13q33. Significant association was detected in single-marker and haplotype tests, with global Pvalues assigned conservatively based on permutation procedures that account for the multiple markers and haplotypes tested. Although the associated alleles and haplotypes differ from those reported previously, these new results provide further support, in an independent case-control sample, for association between BPAD and genetic variation in the vicinity of the G72/G30 locus.
This study is subject to some important limitations. The sample size is not large by current standards. Efficient detection of the weak genetic effects typically encountered with complex phenotypes like BPAD generally requires larger sample sizes. 26 Still, this sample had good power to detect association with a common allele conferring a two-fold or greater increased risk of BPAD in heterozygotes. One advantage of the present sample is that it has been uniformly ascertained and subjected to clinical assessment and diagnosis by trained psychiatrists, usually in a face-to-face interview. In this study, we have not attempted to characterize all genetic variation in and around the G72/G30 locus. Indeed, owing to LD between markers, we have tested only four fully independent SNPs. Our primary aim was to study the same markers as Hattori et al, 7 so that we could test the reported association between those markers and BPAD in an independent sample. We also attempted to better define the extent of the associated haplotypes. Our data suggest that the previously described LD block in the region ends distally between rs947267 and rs954581, but the proximal end remains undefined, as does the functional variant or variants that account for the association.
All case-control studies run a risk of false-positive findings due to population stratification (reviewed in Schulze and McMahon 27 ), although the extent to which such stratification actually contributes to falsepositive findings is controversial. 9, 28 Case-control association studies have the advantage of being less prone than family-based studies to false-positive findings arising from genotyping error, 29, 30 although genotyping errors that do occur are more difficult to detect. We selected our controls from among the founders of a well-studied, and publicly available sample of European-American pedigrees that will allow others to use the same controls in studies of other case samples. The cases and controls were wellmatched on reported ethnicity. Furthermore, analysis of 31 unlinked microsatellite markers genotyped in our cases and controls revealed no evidence of population stratification. Although 68 of the probands in the present sample have at least one parent available, family-based association tests in such a small sample would have low power to detect effect sizes of the magnitude we observed. 26 We could not perform a formal test of linkage partitioning in this sample, 31 since half the cases have no data available from relatives. However, the 68 cases with family data available have undergone linkage analysis with chromosome 13 markers. 11, 6 We used these data to exclude from the sample those cases belonging to families that were clearly not linked to 13q33. The association findings were robust in this enriched sample, but were not substantially stronger. The peak linkage signal in this sample 6 is actually about 30 cM proximal to the G72/G30 region, but stratification of the sample based on that signal did not produce substantially different results (data not shown). Thus, it is possible that the present findings reflect an additional disease locus not detected in the previous linkage studies performed with this sample.
The associated alleles and haplotypes in this sample differ from those reported previously. 7 In this sense, our findings do not replicate the earlier findings. This difference may reflect differences between the two samples in the relative contribution of the 13q33 locus to BPAD, and in the LD patterns around the actual disease locus, but this is unlikely, since both samples were of European ancestry. It is possible that both studies were underpowered to detect all of the 13q33 haplotypes that actually affect BPAD risk in the population. It is also possible that multiple functional variants, variably represented by the SNPs and haplotypes studied, mediate the association between G72/G30 and BPAD. This has been observed, for example, in the drosophila gene delta 32 and in the human b 2 -adrenergic receptor gene. 33 In such a circumstance, multiple SNPs on the same DNA strand could produce effects in concert that would be difficult to evaluate fully unless all functional SNPs were considered.
To our knowledge, this is the first study to provide independent support for a positional candidate gene association finding in the field of BPAD. Our results support the hypothesis that genetic variation in the G72/G30 region contributes to BPAD susceptibility. Further research is needed to determine the functional variation underlying these findings and relate this to the pathophysiology of BPAD.
